Literature DB >> 2125000

Proposed mechanism of induction of gastric carcinoids: the gastrin hypothesis.

R Håkanson1, F Sundler.   

Abstract

Novel, powerful and long-acting inhibitors of gastric acid secretion include second generation H2-blockers and so-called proton pump inhibitors, such as omeprazole. Gastric carcinoids were found to develop in experimental animals as a consequence of continuous long-term administration of several of these highly effective anti secretory drugs. This unwanted side effect is now thought to reflect the fact (1) that pharmacological blockade of acid secretion results in hypergastrinaemia, and (2) that long-standing hypergastrinaemia gives rise to hyperplasia of certain endocrine cells, the so-called ECL cells, in the gastric mucosa. The carcinoids that develop in the rat stomach after lifelong treatment with antisecretagogues arise from the ECL cells. The proposed sequence of events is acid blockade--hypergastrinaemia--ECL cell hyperplasia--carcinoid. This concept, referred to as the gastrin hypothesis, maintains that the ECL cell hyperplasia (and possibly the carcinoids) is a consequence of long-term continuous hypergastrinaemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125000     DOI: 10.1111/j.1365-2362.1990.tb01780.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  14 in total

1.  Smooth Muscle Cell Abnormalities Associated with Gastric ECL Cell Carcinoids.

Authors:  Cesare Bordi; Pietro Caruana; Tiziana D'Adda; Cinzia Azzoni
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

2.  Ultrastructure of ECL cells in Mastomys after long-term treatment with H2 receptor antagonist loxtidine.

Authors:  Reidar Alexander Vigen; Mark Kidd; Irvin M Modlin; Duan Chen; Chun-Mei Zhao
Journal:  Med Mol Morphol       Date:  2012-06       Impact factor: 2.309

Review 3.  Neuroendocrine pathology of the stomach: the Parma contribution.

Authors:  Cesare Bordi
Journal:  Endocr Pathol       Date:  2014-06       Impact factor: 3.943

Review 4.  The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.

Authors:  Jeffrey Copps; Richard F Murphy; Sándor Lovas
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

Review 5.  Chemical carcinogenesis of the gastrointestinal tract in rodents: an overview with emphasis on NTP carcinogenesis bioassays.

Authors:  Sundeep A Chandra; Michael W Nolan; David E Malarkey
Journal:  Toxicol Pathol       Date:  2009-12-17       Impact factor: 1.902

6.  Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.

Authors:  Melanie L Richards; Paul Gauger; Norman W Thompson; Thomas J Giordano
Journal:  World J Surg       Date:  2004-06-16       Impact factor: 3.352

7.  Histamine as an intermediate growth factor in genesis of gastric ECLomas associated with hypergastrinemia in mastomys.

Authors:  I M Modlin; R R Kumar; C J Soroka; H Ahlman; O Nilsson; J R Goldenring
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

Review 8.  New molecular targets for treatment of peptic ulcer disease.

Authors:  Frank Lehmann; Pius Hildebrand; Christoph Beglinger
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 9.  Physiology of the ECL cells.

Authors:  R Håkanson; D Chen; E Lindström; P Norlén; M Björkqvist; D Lehto-Axtelius
Journal:  Yale J Biol Med       Date:  1998 May-Aug

Review 10.  Praomys (Mastomys) natalensis: a model for gastric carcinoid formation.

Authors:  O Nilsson; B Wängberg; L Johansson; I M Modlin; H Ahlman
Journal:  Yale J Biol Med       Date:  1992 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.